Neurodiagnostics Market Research Report by Product (Clinical Testing Instrument, Diagnostic & Imaging System, and Reagent & Consumable), by Indication (Epilepsy, Headache Disorder, Neurodegenerative Diseases, Sleep Disorder, and Stroke), by End User - United States Forecast to 2025 - Cumulative Impact of COVID-19

The United States Neurodiagnostics Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the United States Neurodiagnostics Market.

Market Segmentation & Coverage:

This research report categorizes the Neurodiagnostics to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the Neurodiagnostics Market studied across Clinical Testing Instrument, Diagnostic & Imaging System, and Reagent & Consumable. The Clinical Testing Instrument further studied across NGS Instrument, PCR Instrument, and Sanger Sequencer. The Diagnostic & Imaging System further studied across Angiography System, CT Scanner, EEG System, EMG Device, MEG Device, MRI System, PET Scanner, and Ultrasound Imaging System. The Reagent & Consumable further studied across Antibody, Buffer, Enzyme, Protein, & Peptide, Media & Sera, Probe, and Solvent.

Based on Indication, the Neurodiagnostics Market studied across Epilepsy, Headache Disorder, Neurodegenerative Diseases, Sleep Disorder, and Stroke.

Based on End User, the Neurodiagnostics Market studied across Diagnostic Laboratory & Imaging Center, Hospital & Clinic, Ambulatory Care Center, and Neurology Center.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Neurodiagnostics Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Neurodiagnostics Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the United States Neurodiagnostics Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Neurodiagnostics Market?

4. What is the competitive strategic window for opportunities in the United States Neurodiagnostics Market?

5. What are the technology trends and regulatory frameworks in the United States Neurodiagnostics Market?

6. What are the modes and strategic moves considered suitable for entering the United States Neurodiagnostics Market?

1.1. Objectives of the Study

1.2. Market Segmentation & Coverage

1.3. Years Considered for the Study

1.4. Currency & Pricing

1.5. Language

1.6. Stakeholders

2.1. Research Process

2.1.1. Define: Research Objective

2.1.2. Determine: Research Design

2.1.3. Prepare: Research Instrument

2.1.4. Collect: Data Source

2.1.5. Analyze: Data Interpretation

2.1.6. Formulate: Data Verification

2.1.7. Publish: Research Report

2.1.8. Repeat: Report Update

2.2. Research Execution

2.2.1. Initiation: Research Process

2.2.2. Planning: Develop Research Plan

2.2.3. Execution: Conduct Research

2.2.4. Verification: Finding & Analysis

2.2.5. Publication: Research Report

2.3. Research Outcome

3.1. Market Outlook

3.2. Product Outlook

3.3. Indication Outlook

3.4. End User Outlook

3.5. Competitor Outlook

4.1. Introduction

5.1. Introduction

5.2. Drivers

5.3. Restraints

5.4. Opportunities

5.5. Challenges

6.1. Introduction

6.2. Clinical Testing Instrument

6.2.1. NGS Instrument

6.2.2. PCR Instrument

6.2.3. Sanger Sequencer

6.3. Diagnostic & Imaging System

6.3.1. Angiography System

6.3.2. CT Scanner

6.3.3. EEG System

6.3.4. EMG Device

6.3.5. MEG Device

6.3.6. MRI System

6.3.7. PET Scanner

6.3.8. Ultrasound Imaging System

6.4. Reagent & Consumable

6.4.1. Antibody

6.4.2. Buffer

6.4.3. Enzyme, Protein, & Peptide

6.4.4. Media & Sera

6.4.5. Probe

6.4.6. Solvent

7.1. Introduction

7.2. Epilepsy

7.3. Headache Disorder

7.4. Neurodegenerative Diseases

7.5. Sleep Disorder

7.6. Stroke

8.1. Introduction

8.2. Diagnostic Laboratory & Imaging Center

8.3. Hospital & Clinic

8.4. Ambulatory Care Center

8.5. Neurology Center

9.1. Introduction

9.2. 360iResearch Competitive Strategic Window, by Product

9.3. 360iResearch Competitive Strategic Window, by Indication

9.4. 360iResearch Competitive Strategic Window, by End User

10.1. 360iResearch FPNV Positioning Matrix

10.1.1. Quadrants

10.1.2. Business Strategy

10.1.3. Product Satisfaction

10.2. 360iResearch Market Ranking Analysis

10.3. 360iResearch Market Share Analysis

10.4. 360iResearch Competitive Scenario

10.4.1. Merger & Acquisition

10.4.2. Agreement, Collaboration, & Partnership

10.4.3. New Product Launch & Enhancement

10.4.4. Investment & Funding

10.4.5. Award, Recognition, & Expansion

12.1. Discussion Guide

12.2. Edition Details

12.3. License Details

12.4. Pricing Details

TABLE 1. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, 2017-2025 (USD MILLION)

TABLE 2. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, 2017-2025 (USD MILLION)

TABLE 3. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY NGS INSTRUMENT, 2017-2025 (USD MILLION)

TABLE 4. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY PCR INSTRUMENT, 2017-2025 (USD MILLION)

TABLE 5. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY SANGER SEQUENCER, 2017-2025 (USD MILLION)

TABLE 6. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, 2017-2025 (USD MILLION)

TABLE 7. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY ANGIOGRAPHY SYSTEM, 2017-2025 (USD MILLION)

TABLE 8. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY CT SCANNER, 2017-2025 (USD MILLION)

TABLE 9. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY EEG SYSTEM, 2017-2025 (USD MILLION)

TABLE 10. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY EMG DEVICE, 2017-2025 (USD MILLION)

TABLE 11. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY MEG DEVICE, 2017-2025 (USD MILLION)

TABLE 12. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY MRI SYSTEM, 2017-2025 (USD MILLION)

TABLE 13. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY PET SCANNER, 2017-2025 (USD MILLION)

TABLE 14. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY ULTRASOUND IMAGING SYSTEM, 2017-2025 (USD MILLION)

TABLE 15. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, 2017-2025 (USD MILLION)

TABLE 16. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY ANTIBODY, 2017-2025 (USD MILLION)

TABLE 17. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY BUFFER, 2017-2025 (USD MILLION)

TABLE 18. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY ENZYME, PROTEIN, & PEPTIDE, 2017-2025 (USD MILLION)

TABLE 19. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY MEDIA & SERA, 2017-2025 (USD MILLION)

TABLE 20. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY PROBE, 2017-2025 (USD MILLION)

TABLE 21. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY SOLVENT, 2017-2025 (USD MILLION)

TABLE 22. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2017-2025 (USD MILLION)

TABLE 23. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY HEADACHE DISORDER, 2017-2025 (USD MILLION)

TABLE 24. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2017-2025 (USD MILLION)

TABLE 25. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY SLEEP DISORDER, 2017-2025 (USD MILLION)

TABLE 26. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2017-2025 (USD MILLION)

TABLE 27. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORY & IMAGING CENTER, 2017-2025 (USD MILLION)

TABLE 28. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY HOSPITAL & CLINIC, 2017-2025 (USD MILLION)

TABLE 29. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTER, 2017-2025 (USD MILLION)

TABLE 30. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY NEUROLOGY CENTER, 2017-2025 (USD MILLION)

TABLE 31. UNITED STATES NEURODIAGNOSTICS MARKET: SCORES

TABLE 32. UNITED STATES NEURODIAGNOSTICS MARKET: BUSINESS STRATEGY

TABLE 33. UNITED STATES NEURODIAGNOSTICS MARKET: PRODUCT SATISFACTION

TABLE 34. UNITED STATES NEURODIAGNOSTICS MARKET: RANKING

TABLE 35. UNITED STATES NEURODIAGNOSTICS MARKET: MERGER & ACQUISITION

TABLE 36. UNITED STATES NEURODIAGNOSTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP

TABLE 37. UNITED STATES NEURODIAGNOSTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT

TABLE 38. UNITED STATES NEURODIAGNOSTICS MARKET: INVESTMENT & FUNDING

TABLE 39. UNITED STATES NEURODIAGNOSTICS MARKET: AWARD, RECOGNITION, & EXPANSION

TABLE 40. UNITED STATES NEURODIAGNOSTICS MARKET: EDITION DETAILS

TABLE 41. UNITED STATES NEURODIAGNOSTICS MARKET: LICENSE DETAILS

TABLE 42. UNITED STATES NEURODIAGNOSTICS MARKET: PRICING DETAILS